Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study

October 2023 in “ Cancers ”

Ana Morelló‐Vicente, Marta Espejo-Marín, Inés Oteiza‐Rius, Javier Antoñanzas, Antonio Vélez, Rafael Salido‐Vallejo

cutaneous squamous cell carcinoma cSCC sun-exposed skin local recurrence tumor thickness positive surgical margins skin cancer sun-exposed areas recurrence tumor size surgical margins

TLDR Skin cancer in sun-exposed areas is more likely to come back.

This retrospective cohort study involving 558 patients with cutaneous squamous cell carcinoma (cSCC) found that tumors in highly sun-exposed areas (head, neck, dorsum of hands) had a significantly higher rate of local recurrence (15.8%) compared to those in less sun-exposed areas (7.4%). No significant differences were observed in metastasis rates between the two groups. Independent risk factors for recurrence in low sun-exposure areas included tumor thickness and positive surgical margins. The findings suggest that cSCCs in highly sun-exposed regions may have a worse prognosis due to a higher likelihood of local recurrence.

View this study on mdpi.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 12 results

community How do you use rosemary oil and peppermint oil?

in Question 6 upvotes 4 years ago

Rosemary oil and peppermint oil may promote hair growth and increase cutaneous blood flow, showing promise as treatments for androgenetic alopecia. Minoxidil 2% is also used for treating hair loss.

community Scientific evidence for Peppermint & Rosemary oils + My Experience

in Research/Science 114 upvotes 2 years ago

Natural treatments for hair loss, specifically peppermint oil and rosemary oil; how they can be used as a supplementary or alternative treatment to pharmaceuticals such as finasteride and minoxidil; and the personal experience of the user Divallo, who has seen an increase in density and thickness after using these oils for around 2.5 years. The post also touches on the potential antifungal properties of the oils and their effects on cutaneous blood flow.

community high bloodpressure and crown thinning in early 20s

in Is this regrowth? 9 upvotes 6 months ago

A user with kidney disease and high blood pressure experienced hair thinning, especially around the vertex. They are currently using finasteride and oral minoxidil but are considering whether to resume blood pressure medication despite managing symptoms with diet and exercise.

community HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

in Research/Science 112 upvotes 1 year ago

Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.

community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

in Research/Science 65 upvotes 1 year ago

Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

community Why is everyone not directly advised Dutasteride?

in Finasteride/Dutasteride 167 upvotes 2 months ago

Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.

Similar Research

5 / 1000+ results

Skin Cancer: Understanding the Transformation from Conventional to Advanced Treatment Approaches

research Targeting the Hippo/YAP/TAZ Signalling Pathway: Novel Opportunities for Therapeutic Interventions into Skin Cancers

7 citations, August 2022 in “Experimental dermatology”

Blocking YAP/TAZ could be a new way to treat skin cancer.